Vyome (HIND) Stock: Why It's Down Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $1.86 as of 12:05 PM ET, -0.53% vs the prior close of $1.87.
- Volume 5.16K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HIND dips 0.5% to $1.86, a 52-week low, 6 down days in a row. Trading at $1.86 (intraday, 12:05 PM ET), -0.53% vs the prior close of $1.87. Day range $1.85–$1.86, opened at $1.85.
HIND daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — HIND dips 0.5% to $1.86, a 52-week low, 6 down days in a row
- Trading at $1.86 (intraday, 12:05 PM ET), -0.53% vs the prior close of $1.87. Day range $1.85–$1.86, opened at $1.85.
- Volume was 5.16K shares, 0.4x its 50-day average of 13.76K — lighter than usual.
- Price is -10.8% vs its 50-day average ($2.09) and -19.5% vs its 200-day average ($2.31).
- 52-week range $1.75–$6.56; the current price sits at 2% of that range, 71.6% below the 52-week high.
- That makes 6 straight losses.
Oct 16, 2026 — HIND dips 2.1% to $1.87, a 52-week low, 5 down days in a row
- Closed at $1.87, -2.09% vs the prior close of $1.91. Day range $1.86–$1.91, opened at $1.89.
- Volume was 11.23K shares, 0.8x its 50-day average of 13.58K.
- Price is -10.6% vs its 50-day average ($2.09) and -19.4% vs its 200-day average ($2.32).
- 52-week range $1.75–$6.56; today's close sits at 2% of that range, 71.5% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — HIND dips 1.0% to $1.91, 4 down days in a row
- Closed at $1.91, -1.04% vs the prior close of $1.93. Day range $1.83–$1.93, opened at $1.92.
- Volume was 15.00K shares, 1.1x its 50-day average of 13.48K.
- Price is -8.9% vs its 50-day average ($2.10) and -17.9% vs its 200-day average ($2.33).
- 52-week range $1.75–$6.56; today's close sits at 3% of that range, 70.9% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — HIND dips 2.0% to $1.93, 3 down days in a row
- Closed at $1.93, -2.03% vs the prior close of $1.97. Day range $1.91–$1.98, opened at $1.94.
- Volume was 6.30K shares, 0.5x its 50-day average of 13.47K — lighter than usual.
- Price is -8.2% vs its 50-day average ($2.10) and -17.4% vs its 200-day average ($2.34).
- 52-week range $1.75–$6.56; today's close sits at 4% of that range, 70.6% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — HIND dips 2.0% to $1.97
- Closed at $1.97, -1.99% vs the prior close of $2.01. Day range $1.95–$2.09, opened at $2.09.
- Volume was 10.00K shares, 0.7x its 50-day average of 13.49K.
- Price is -6.5% vs its 50-day average ($2.11) and -16.0% vs its 200-day average ($2.35).
- 52-week range $1.75–$6.56; today's close sits at 5% of that range, 70.0% below the 52-week high.
Oct 12, 2026 — HIND slides 3.8% to $2.01
- Closed at $2.01, -3.83% vs the prior close of $2.09. Day range $1.99–$2.05, opened at $2.04.
- Volume was 7.10K shares, 0.5x its 50-day average of 13.81K — lighter than usual.
- Price is -4.8% vs its 50-day average ($2.11) and -14.6% vs its 200-day average ($2.35).
- 52-week range $1.75–$6.56; today's close sits at 5% of that range, 69.4% below the 52-week high.
Oct 9, 2026 — HIND rises 3.0% to $2.09
- Closed at $2.09, +2.96% vs the prior close of $2.03. Day range $2.01–$2.09, opened at $2.03.
- Volume was 7.60K shares, 0.6x its 50-day average of 13.70K — lighter than usual.
- Price is -1.1% vs its 50-day average ($2.11) and -11.5% vs its 200-day average ($2.36).
- 52-week range $1.75–$6.56; today's close sits at 7% of that range, 68.1% below the 52-week high.
Oct 8, 2026 — HIND dips 0.5% to $2.03
- Closed at $2.03, -0.49% vs the prior close of $2.04. Day range $1.98–$2.03, opened at $2.03.
- Volume was 8.00K shares, 0.6x its 50-day average of 13.65K — lighter than usual.
- Price is -3.9% vs its 50-day average ($2.11) and -14.4% vs its 200-day average ($2.37).
- 52-week range $1.75–$6.56; today's close sits at 6% of that range, 69.1% below the 52-week high.
Oct 7, 2026 — HIND dips 1.0% to $2.04
- Closed at $2.04, -0.97% vs the prior close of $2.06. Day range $1.98–$2.06, opened at $2.02.
- Volume was 11.40K shares, 0.8x its 50-day average of 13.62K.
- Price is -3.3% vs its 50-day average ($2.11) and -14.3% vs its 200-day average ($2.38).
- 52-week range $1.75–$6.56; today's close sits at 6% of that range, 68.9% below the 52-week high.
Oct 6, 2026 — HIND jumps 6.7% to $2.06
- Closed at $2.06, +6.74% vs the prior close of $1.93. Day range $1.90–$2.07, opened at $2.01.
- Volume was 13.70K shares, 1.0x its 50-day average of 13.47K.
- Price is -2.3% vs its 50-day average ($2.11) and -13.8% vs its 200-day average ($2.39).
- 52-week range $1.75–$6.56; today's close sits at 6% of that range, 68.6% below the 52-week high.
Oct 5, 2026 — HIND rises 1.0% to $1.93
- Closed at $1.93, +1.05% vs the prior close of $1.91. Day range $1.90–$2.00, opened at $1.90.
- Volume was 10.20K shares, 0.8x its 50-day average of 13.46K.
- Price is -8.5% vs its 50-day average ($2.11) and -19.5% vs its 200-day average ($2.40).
- 52-week range $1.75–$6.56; today's close sits at 4% of that range, 70.6% below the 52-week high.
Oct 2, 2026 — HIND dips 0.5% to $1.91, a 3-month low, 6 down days in a row
- Closed at $1.91, -0.52% vs the prior close of $1.92. Day range $1.82–$1.96, opened at $1.84.
- Volume was 20.20K shares, 1.5x its 50-day average of 13.18K.
- Price is -9.5% vs its 50-day average ($2.11) and -20.7% vs its 200-day average ($2.41).
- 52-week range $1.75–$6.56; today's close sits at 3% of that range, 70.9% below the 52-week high.
- That makes 6 straight losses.
HIND bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Price is -10.8% vs its 50-day average — short-term trend is down.
- Price is -19.5% vs its 200-day average — below the long-term trend line.
- Annual revenue fell 7.7% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $10.26M.
- Share count up 160.6% in a year (dilution).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
HIND latest news & SEC filings
Every SEC filing by or about HIND in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 1, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $26.95K (prior year $49.95K) (-46.0% vs Jun 30, 2025)
- Net income: -$685.56K (prior year -$308.76K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.10 (prior year -$799.90) (loss narrowed vs Jun 30, 2025)
Things to know before you trade HIND
- Last results release: Aug 25, 2026 (8-K Item 2.02). Previous ones: May 29, 2026, Nov 19, 2025, Nov 14, 2024. Based on that rhythm, the next report is likely around Nov 24, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.89% (largest 6.7%).
- Liquidity: about 10.06K shares (≈$18.71K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.86 vs a range of $1.75–$6.56 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:4 on Aug 15, 2025, 1:25 on May 9, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Aug 28, 2026; 8-K Aug 25, 2026; 10-Q Aug 12, 2026.
- Share count: 7.02M shares outstanding (Aug 12, 2026), +160.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
HIND market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 1.85 | 1.86 | 1.85 | 1.86 | 5.16K |
| Oct 16, 2026 | 1.89 | 1.91 | 1.86 | 1.87 | 11.20K |
| Oct 15, 2026 | 1.92 | 1.93 | 1.83 | 1.91 | 15.00K |
| Oct 14, 2026 | 1.94 | 1.98 | 1.91 | 1.93 | 6.30K |
| Oct 13, 2026 | 2.09 | 2.09 | 1.95 | 1.97 | 10.00K |
| Oct 12, 2026 | 2.04 | 2.05 | 1.99 | 2.01 | 7.10K |
| Oct 9, 2026 | 2.03 | 2.09 | 2.01 | 2.09 | 7.60K |
| Oct 8, 2026 | 2.03 | 2.03 | 1.98 | 2.03 | 8.00K |
| Oct 7, 2026 | 2.02 | 2.06 | 1.98 | 2.04 | 11.40K |
| Oct 6, 2026 | 2.01 | 2.07 | 1.90 | 2.06 | 13.70K |
| Oct 5, 2026 | 1.90 | 2.00 | 1.90 | 1.93 | 10.20K |
| Oct 2, 2026 | 1.84 | 1.96 | 1.82 | 1.91 | 20.20K |
| Oct 1, 2026 | 1.93 | 2.00 | 1.91 | 1.92 | 8.50K |
| Sep 30, 2026 | 1.93 | 2.04 | 1.90 | 1.93 | 7.50K |
| Sep 29, 2026 | 1.99 | 2.02 | 1.99 | 2.02 | 8.60K |
| Sep 28, 2026 | 2.01 | 2.06 | 2.01 | 2.03 | 5.10K |
| Sep 25, 2026 | 2.07 | 2.08 | 2.01 | 2.04 | 9.30K |
| Sep 24, 2026 | 2.03 | 2.08 | 2.03 | 2.06 | 6.30K |
| Sep 23, 2026 | 1.98 | 2.01 | 1.95 | 2.01 | 5.40K |
| Sep 22, 2026 | 2.00 | 2.09 | 1.91 | 1.95 | 24.60K |
About Vyome
Vyome (HIND) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN CLEMENTE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1427570.
HIND board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mohanjit Jolly | Director | Sep 3, 2026 |
| Venkateswarlu Nelabhotla | President and CEO | Nov 17, 2025 |
| Stanley D Iii Pomichter | Director | Nov 19, 2025 |
| Shiladitya Sengupta | Director | Nov 17, 2025 |
| John M. Iii Tincoff | Director | Nov 17, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jerry Leonard | Chief Financial Officer | Sep 1, 2026 |
| Venkateswarlu Nelabhotla | President and CEO | Nov 17, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
HIND financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-10.26M | -4.86 | $-3.75M |
| Dec 31, 2024 | $8.01M | $-1.45M | -6,001.39 | $-614.14K |
| Dec 31, 2023 | $8.68M | $-11.39M | -110.87 | $-16.96M |
| Dec 31, 2022 | $11.24M | $-46.21M | -108.90 | $-21.90M |
| Dec 31, 2021 | $13.60M | $-63.15M | -288.97 | $-15.38M |
Latest balance sheet: total assets $9.18M, total liabilities $1.86M, cash $7.89M (as of Jun 30, 2026).
HIND earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 25, 2026 | 8-K Item 2.02 (results) | $2.23 |
| May 29, 2026 | 8-K Item 2.02 (results) | $2.34 |
| Nov 19, 2025 | 8-K Item 2.02 (results) | $4.61 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $517.00 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 20, 2024 | 8-K Item 2.02 (results) | — |
| Apr 4, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
| Aug 7, 2023 | 8-K Item 2.02 (results) | — |
| May 16, 2023 | 8-K Item 2.02 (results) | — |
| Nov 14, 2022 | 8-K Item 2.02 (results) | — |
| Aug 16, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on HIND
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.